ArticleBMC endocrine disorders2023

Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: a protocol for a multicenter, parallel-group, randomized, controlled, open-label trial.

Xue Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.